Clincosm LogoSign in Get a demo

Ovarian Cancer

Showing NaN - NaN of 161
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer Trial in Houston (Pembrolizumab, Bevacizumab, Cyclophosphamide)

Not yet recruiting
  • Ovarian Cancer
  • Houston, Texas
    MD Anderson Cancer Center
Oct 9, 2023

Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +19 more
  • A2B694
  • xT CDx with HLA-LOH Assay
  • Duarte, California
  • +9 more
Sep 22, 2023

Ovarian Cancer Trial in Houston (Shared Medical Decision Tool, Engaging Patients in Decision Making, Literacy Spanish Language)

Recruiting
  • Ovarian Cancer
  • Shared Medical Decision Tool
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 7, 2023

Solid Tumor, Breast Cancer, Pancreatic Cancer Trial in United States (SON-DP)

Recruiting
  • Solid Tumor
  • +4 more
  • Gilbert, Arizona
  • +4 more
Aug 4, 2023

Pancreatic Cancer, Ovarian Cancer, Adenocarcinoma Trial in Houston (TROP2-CAR-NK, Cyclophosphamide, Fludarabine)

Not yet recruiting
  • Pancreatic Cancer
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 27, 2023

Ovarian Cancer Trial in Houston (Hyperpolarized 13-C-pyruvate)

Not yet recruiting
  • Ovarian Cancer
  • Hyperpolarized 13-C-pyruvate
  • Houston, Texas
    M D Anderson Cancer Center
May 10, 2023

Ovarian Cancer, Lung Adenocarcinoma Trial in United States (AZD5335, AZD5305)

Not yet recruiting
  • Ovarian Cancer
  • Lung Adenocarcinoma
  • Duarte, California
  • +6 more
Mar 21, 2023

Advanced or Metastatic Solid Tumors, Breast Cancer, Ovarian Cancer Trial in Houston (IDE-161)

Not yet recruiting
  • Advanced or Metastatic Solid Tumors
  • +4 more
  • Houston, Texas
    MD Anderson
Mar 27, 2023

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Houston (Paclitaxel, Carboplatin, Bevacizumab)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 13, 2023

Ovarian Cancer Trial in Houston (Nivolumab, Etigilimab)

Not yet recruiting
  • Ovarian Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Jan 27, 2023

Endometrial Cancer, Esophageal Cancer, Esophagogastric Junction (EGJ) Trial in Worldwide (Autologous genetically modified

Recruiting
  • Endometrial Cancer
  • +8 more
  • Autologous genetically modified ADP-A2M4CD8 cells alone or in combination with nivolumab every four weeks or pembrolizumab every 6 weeks
  • Orlando, Florida
  • +21 more
Feb 2, 2023

Ovarian Cancer Trial in Worldwide (Ipatasertib, Cobimetinib, Trastuzumab Emtansine)

Recruiting
  • Ovarian Cancer
  • Tucson, Arizona
  • +60 more
Jan 20, 2023

Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)

Recruiting
  • Minimal Residual Disease
  • +11 more
  • ELI-002 2P
  • Duarte, California
  • +10 more
Jan 18, 2023

Solid Tumor, Non Small Cell Lung Cancer, Pancreatic Cancer Trial in Israel, United States (CM-24 and Nivolumab - Dose

Recruiting
  • Solid Tumor
  • +6 more
  • CM-24 and Nivolumab - Dose Escalation
  • +4 more
  • Scottsdale, Arizona
  • +10 more
Jan 17, 2023

Advanced Cancer, Metastatic Cancer, Ovarian Cancer Trial in Sarasota, Nashville (DS-9606a)

Recruiting
  • Advanced Cancer
  • +3 more
  • Denver, Colorado
  • +6 more
Jan 12, 2023

Advanced Malignancies, NSCLC, Ovarian Cancer Trial in Worldwide (Avelumab, Lorlatanib, Talazoparib)

Recruiting
  • Advanced Malignancies
  • +4 more
  • Fayetteville, Arkansas
  • +61 more
Jan 10, 2023

NSCLC, Gastric Carcinoma, Gastroesophageal Junction Carcinoma Trial in Worldwide (SEA-TGT, sasanlimab)

Recruiting
  • Non-small Cell Lung Cancer
  • +11 more
  • Birmingham, Alabama
  • +32 more
Jan 4, 2023

Ovarian Cancer, Cervical Cancer, Endometrial Cancer Trial in Worldwide (Enapotamab vedotin (HuMax-AXL-ADC))

Completed
Has Results
  • Ovarian Cancer
  • +7 more
  • Enapotamab vedotin (HuMax-AXL-ADC)
  • Phoenix, Arizona
  • +40 more
Dec 12, 2022

Biliary Tract Cancer (BTC), Colorectal Cancer (CRC), Endometrial Cancer Trial in Belgium, United Kingdom, United States

Completed
  • Biliary Tract Cancer (BTC)
  • +5 more
  • Birmingham, Alabama
  • +9 more
Dec 22, 2022

Advanced Solid Malignancy, Safety and Tolerability, Pharmacokinetics Trial in Worldwide (AZD5363)

Active, not recruiting
  • Advanced Solid Malignancy
  • +13 more
  • Los Angeles, California
  • +33 more
Dec 22, 2022

NSCLC, Ovarian Cancer, Melanoma Trial in Worldwide (LXH254, PDR001)

Terminated
  • NSCLC
  • +3 more
  • Boston, Massachusetts
  • +17 more
Dec 20, 2022

NSCLC, Pancreatic Cancer, Colorectal Cancer Trial in Canada, United States (PF-06946860, Placebo for PF-06946860)

Completed
  • Non-small Cell Lung Cancer
  • +9 more
  • Little Rock, Arkansas
  • +32 more
Dec 12, 2022

Ovarian Cancer, Breast Cancer, Colorectal Cancer Trial in Houston (Genetic Testing and Counseling, Screening Form)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Genetic Testing and Counseling
  • Screening Form
  • Houston, Texas
    M D Anderson Cancer Center
Dec 12, 2022

Ovarian Cancer, Fallopian Tube Cancer Trial in Houston (RIsk-Reducing Salpingectomy (RRS), Risk-Reducing Oophorectomy-RRO,

Recruiting
  • Ovarian Cancer
  • Fallopian Tube Cancer
  • RIsk-Reducing Salpingectomy (RRS)
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Advanced or Metastatic Solid Tumors, Microsatellite Instability Low, Microsatellite Instability High Trial in United States

Recruiting
  • Advanced or Metastatic Solid Tumors
  • +11 more
  • Tucson, Arizona
  • +11 more
Dec 2, 2022